News

Five Fellows will work with innovators across Harvard community, advance commercialization of life-science technologies

New formulations enable oral delivery of therapeutics traditionally delivered intravenously

Genetically programmed, living hydrogel material facilitates intestinal wound healing and may lead to a therapy for patients with inflammatory bowel disease

Accelerator-funded research points to potential therapy for heightened touch sensitivity in autism spectrum disorders

Based on innovations from Harvard University and Boston Children's Hospital, Nocion Therapeutics aims to selectively silence pain and itch neurons